The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Healthcare resource utilization and economic burden of cytokine release syndrome (CRS) and neurologic events (NE) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) receiving idecabtagene vicleucel (ide-cel, bb2121) in KarMMa.
 
Parameswaran Hari
Honoraria - Amgen; Bristol-Myers Squibb; Janssen Oncology; Juno Therapeutics; Karyopharm Therapeutics; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Sanofi; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Andy Nguyen
Employment - BluePath Solutions
 
Corey Pelletier
Employment - Bristol Myers Squibb Foundation
 
November McGarvey
Employment - BluePath Solutions
 
Matthew Gitlin
Employment - BluePath Solutions
 
Kejal Parikh
Employment - Bristol-Myers Squibb